Pittsburgh Life Sciences Greenhouse is an incubator firm in Pittsburgh that supports life sciences start-ups, recruiting star university researchers and seasoned life science executives to the region. Founded 2002 in Pittsburgh, Pennsylvania, United States, it invests in early stage ventures, late stage ventures, seed, debt financing, series C, and series A ventures. Its portfolio companies include Cognition Therapeutics, Clinical Platform, ALung Technologies, and Carmell Therapeutics. As of February 2020, Pittsburgh Life Sciences Greenhouse has made 52 investments. Their most recent investment was on June 6, 2019, when Clinical Platform raised $20K. Pittsburgh Life Sciences Greenhouse has had three exits, the most notable exits include Applied Computational Technologies, Cellumen, and PeriOptimum. Pittsburgh Life Sciences Greenhouse has raised two funds, their latest being PLSG Accelerator Fund II. This fund was announced on May 1, 2017 and raised a total of $5.2M.